 prohibitive,
HL&S is an acceptable strategy

Unknown

Is the option acceptable to key
stakeholders?

All studies showed either strategy is
acceptable compared with no therapy;
individuals who place high priority on longterm outcomes would likely not choose
UGFS

Probably yes

Is the option feasible to implement?

Yes, it is a widely adopted technology; HL&S
can be used if technology or expertise for
endovenous ablation is not available or
venous anatomy precludes